CIRM Funded Clinical Trials
Optogenetic Therapy for Treatment of Stargardt Disease
Disease Area:
Age-related macular degeneration
Trial Sponsor:
Ray Therapeutics, INC
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A